• Beatriz Godínez-Chaparro, Uriah Guevara-López, Minarda de la O-Arciniega, Alma Rosa Cortés-Arroyo, and Francisco Javier López-Muñoz.
• Departamento de Farmacobiología, Cinvestav-Sede Sur, México, D.F., Mexico.
• Cir Cir. 2007 Sep 1; 75 (5): 371-6.

BackgroundThe antinociceptive effects of metamizol and morphine administered either separately or in combination were determined in the "Pain-Induced Functional Impairment Model in the Rat" (PIFIR antinociceptive model).MethodsIntense nociception (or intense pain) was induced by the intra-articular injection of uric acid (50%) in the right hind limb inducing its dysfunction. Animals then received analgesic agents, and the recovery of functionality over time was assessed as an expression of antinociception.ResultsMetamizol (177.8 mg/kg s.c.) or morphine (3.2 mg/kg s.c.) separately resulted in a lower antinociceptive effect (22.1+/-5.4 area units [au] and 31.8+/-9.4 au, respectively). Moreover, the combination of metamizol (177.8 mg/kg) with morphine (3.2 mg/kg) resulted in a potentiation (293.7+/-16.6 au). The antinociceptive effect observed using the combination was significantly greater than expected on the basis of addition of the individual effects. The percent change in antinociceptive effects, using the combination, was 444.9%.ConclusionsThis represents the first study to show that metamizol + morphine can produce potentiation of their antinociceptive effects in intense pain.

23 keywords...

hide…